{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:13:29Z","timestamp":1780467209407,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,1,11]],"date-time":"2008-01-11T00:00:00Z","timestamp":1200009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s00259-007-0686-9","type":"journal-article","created":{"date-parts":[[2008,1,10]],"date-time":"2008-01-10T05:44:55Z","timestamp":1199943895000},"page":"976-983","source":"Crossref","is-referenced-by-count":90,"title":["The value of 18F-Choline PET\/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer"],"prefix":"10.1007","volume":"35","author":[{"given":"I.","family":"Igerc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kohlf\u00fcrst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. J.","family":"Gallowitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Matschnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kresnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Gomez-Segovia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,11]]},"reference":[{"issue":"9360","key":"686_CR1","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0140-6736(03)12713-4","volume":"361","author":"H Gronberg","year":"2003","unstructured":"Gronberg H. Prostate cancer epidemiology. Lancet. 2003;361(9360):859-64.","journal-title":"Lancet."},{"issue":"17","key":"686_CR2","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","volume":"324","author":"WJ Catalona","year":"1991","unstructured":"Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324(17):1156-61. Erratum in: N Engl J Med 1991;325(18):1324.","journal-title":"N Engl J Med"},{"issue":"3 Pt 2","key":"686_CR3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0022-5347(17)37401-3","volume":"147","author":"MK Brawer","year":"1992","unstructured":"Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, Lange PH. Screening for prostatic carcinoma with prostate specific antigen. J Urol. 1992;147(3 Pt 2):841-5.","journal-title":"J Urol."},{"issue":"2","key":"686_CR4","first-page":"123","volume":"56","author":"M Roscigno","year":"2004","unstructured":"Roscigno M, Scattoni V, Bertini R, Pasta A, Montorsi F, Rigatti P. Diagnosis of prostate cancer. State of the art. Minerva Urol Nefrol. 2004;56(2):123-45.","journal-title":"Minerva Urol Nefrol."},{"issue":"22","key":"686_CR5","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1056\/NEJMoa031918","volume":"350","author":"IM Thompson","year":"2004","unstructured":"Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med. 2004;350(22):2239-46.","journal-title":"N Engl J Med."},{"issue":"5","key":"686_CR6","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/S0022-5347(01)67444-5","volume":"153","author":"WJ Ellis","year":"1995","unstructured":"Ellis WJ, Brawer MK. Repeat prostate needle biopsy: who needs it? J Urol. 1995;153(5):1496-8.","journal-title":"J Urol."},{"issue":"2","key":"686_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0022-5347(01)64518-X","volume":"158","author":"NE Fleshner","year":"1997","unstructured":"Fleshner NE, O'Sullivan M, Fair WR. Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. J Urol. 1997;158(2):505-8. discussion 508-9.","journal-title":"J Urol."},{"issue":"4","key":"686_CR8","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S0022-5347(01)63574-2","volume":"159","author":"F Rabbani","year":"1998","unstructured":"Rabbani F, Stroumbakis N, Kava BR, Cookson MS, Fair WR. Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol. 1998 Apr;159(4):1247-50.","journal-title":"J Urol."},{"issue":"5","key":"686_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0090-4295(02)02520-7","volume":"61","author":"S Kravchick","year":"2003","unstructured":"Kravchick S, Cytron S, Peled R, Altshuler A, Ben-Dor D. Using gray-scale and two different techniques of color Doppler sonography to detect prostate cancer. Urology. 2003;61(5):977-81.","journal-title":"Urology."},{"issue":"2","key":"686_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1148\/radiology.213.2.r99nv23473","volume":"213","author":"J Scheidler","year":"1999","unstructured":"Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology. 1999;213(2):473-80.","journal-title":"Radiology."},{"issue":"2","key":"686_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0022-5347(01)63916-8","volume":"159","author":"CK Hoh","year":"1998","unstructured":"Hoh CK, Seltzer MA, Franklin J, deKernion JB, Phelps ME, Belldegrun A. Positron emission tomography in urological oncology. J Urol. 1998;159(2):347-56.","journal-title":"J Urol."},{"issue":"3","key":"686_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1148\/radiology.199.3.8638000","volume":"199","author":"PD Shreve","year":"1996","unstructured":"Shreve PD, Grossman HB, Gross MD, Wahl RL. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. Radiology. 1996;199(3):751-6. Jun.","journal-title":"Radiology."},{"issue":"6","key":"686_CR13","first-page":"990","volume":"39","author":"T Hara","year":"1998","unstructured":"Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med. 1998;39(6):990-5.","journal-title":"J Nucl Med."},{"issue":"3","key":"686_CR14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0006-291X(02)00920-8","volume":"296","author":"A Ramirez de Molina","year":"2002","unstructured":"Ramirez de Molina A, Rodriguez-Gonzalez A, Gutierrez R, Martinez-Pineiro L, Sanchez J, Bonilla F, et al. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun. 2002;296(3):580-3.","journal-title":"Biochem Biophys Res Commun."},{"issue":"1","key":"686_CR15","first-page":"80","volume":"59","author":"EO Aboagye","year":"1999","unstructured":"Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res. 1999 Jan 1;59(1):80-4.","journal-title":"Cancer Res."},{"issue":"1","key":"686_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0022-5347(05)64906-3","volume":"168","author":"DT Price","year":"2002","unstructured":"Price DT, Coleman RE, Liao RP, Robertson CN, Polascik TJ, DeGrado TR. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol. 2002;168(1):273-80.","journal-title":"J Urol."},{"issue":"3","key":"686_CR17","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0022-5347(05)67809-3","volume":"163","author":"FH Schroder","year":"2000","unstructured":"Schroder FH, van der Cruijsen-Koeter I, de Koning HJ, Vis AN, Hoedemaeker RF, Kranse R. Prostate cancer detection at low prostate specific antigen. J Urol. 2000;163(3):806-12.","journal-title":"J Urol."},{"issue":"6","key":"686_CR18","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0022-5347(17)35304-1","volume":"151","author":"DW Keetch","year":"1994","unstructured":"Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol. 1994;151(6):1571-4.","journal-title":"J Urol."},{"issue":"5","key":"686_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/nbm.1940050518","volume":"5","author":"W Negendank","year":"1992","unstructured":"Negendank W. Studies of human tumors by MRS: a review. NMR Biomed. 1992;5(5):303-24.","journal-title":"NMR Biomed."},{"issue":"4","key":"686_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1349-7006.1999.tb00764.x","volume":"90","author":"K Nakagami","year":"1999","unstructured":"Nakagami K, Uchida T, Ohwada S, Koibuchi Y, Suda Y, Sekine T, Morishita Y. Increased choline kinase activity and elevated phosphocholine levels in human colon cancer. Jpn J Cancer Res. 1999;90(4):419-24.","journal-title":"Jpn J Cancer Res."},{"issue":"1","key":"686_CR21","first-page":"110","volume":"61","author":"TR DeGrado","year":"2001","unstructured":"DeGrado TR, Coleman RE, Wang S, Baldwin SW, Orr MD, Robertson CN, et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res. 2001;61(1):110-7.","journal-title":"Cancer Res."},{"issue":"1","key":"686_CR22","first-page":"92","volume":"43","author":"TR DeGrado","year":"2002","unstructured":"DeGrado TR, Reiman RE, Price DT, Wang S, Coleman RE. Pharmacokinetics and radiation dosimetry of 18F-fluorocholine. J Nucl Med. 2002;43(1):92-6.","journal-title":"J Nucl Med."},{"issue":"2","key":"686_CR23","first-page":"262","volume":"47","author":"SA Kwee","year":"2006","unstructured":"Kwee SA, Wei H, Sesterhenn I, Yun D, Coel MN. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET. J Nucl Med. 2006;47(2):262-9.","journal-title":"J Nucl Med."},{"issue":"4","key":"686_CR24","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/ijc.2910550413","volume":"55","author":"L Hakalahti","year":"1993","unstructured":"Hakalahti L, Vihko P, Henttu P, Autio-Harmainen H, Soini Y, Vihko R. Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies. Int J Cancer. 1993;55(4):590-7.","journal-title":"Int J Cancer."},{"key":"686_CR25","first-page":"187","volume":"43","author":"MT Wyss","year":"2004","unstructured":"Wyss MT, Weber B, Honer M, Spath N, Ametamey SM, Westera G, et al. 18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET. Eur J Nucl Med Mol Imaging 2004;43:187-99.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"686_CR26","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1148\/radiol.2352040494","volume":"235","author":"DT Schmid","year":"2005","unstructured":"Schmid DT, John H, Zweifel R, Cservenyak T, Westera G, Goerres GW, et al. Fluorocholine PET\/CT in patients with prostate cancer: initial experience. Radiology. 2005;235(2):623-8.","journal-title":"Radiology."},{"issue":"6","key":"686_CR27","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/S0022-5347(05)68090-1","volume":"162","author":"LD True","year":"1999","unstructured":"True LD, Berger RE, Rothman I, Ross SO, Krieger JN. Prostate histopathology and the chronic prostatitis\/chronic pelvic pain syndrome: a prospective biopsy study. J Urol. 1999;162(6):2014-8.","journal-title":"J Urol."},{"issue":"3","key":"686_CR28","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1148\/radiol.2313031391","volume":"231","author":"A Shukla-Dave","year":"2004","unstructured":"Shukla-Dave A, Hricak H, Eberhardt SC, Olgac S, Muruganandham M, Scardino PT, et al. Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings-initial observations. Radiology. 2004;231(3):717-24.","journal-title":"Radiology."},{"issue":"4","key":"686_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S1536-1632(02)00015-X","volume":"4","author":"T Hara","year":"2002","unstructured":"Hara T. 11C-choline and 2-deoxy-2-[18F]fluoro-D-glucose in tumor imaging with positron emission tomography. Mol Imaging Biol. 2002;4(4):267-73.","journal-title":"Mol Imaging Biol."},{"issue":"3","key":"686_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00259-003-1377-9","volume":"31","author":"E Sutinen","year":"2004","unstructured":"Sutinen E, Nurmi M, Roivainen A, Varpula M, Tolvanen T, Lehikoinen P, et al. Kinetics of [(11)C]choline uptake in prostate cancer: a PET study. Eur J Nucl Med Mol Imaging. 2004;31(3):317-24.","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"1","key":"686_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00259-006-0190-7","volume":"34","author":"B Scher","year":"2007","unstructured":"Scher B, Seitz M, Albinger W, Tiling R, Scherr M, Becker HC, et al. Value of (11)C-choline PET and PET\/CT in patients with suspected prostate cancer. Eur J Nucl Med Mol Imaging. 2007;34(1):45-53.","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"Suppl2","key":"686_CR32","first-page":"S2","volume":"3","author":"ED Crawford","year":"2001","unstructured":"Crawford ED, Miller GJ, Labrie F, Hirano D, Batuello J, Glode LM. Prostate cancer pathology, screening, and epidemiology. Rev Urol. 2001;3(Suppl2):S2-S10.","journal-title":"Rev Urol."}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-007-0686-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-007-0686-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-007-0686-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-007-0686-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:01:36Z","timestamp":1558699296000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-007-0686-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,11]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["686"],"URL":"https:\/\/doi.org\/10.1007\/s00259-007-0686-9","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,11]]}}}